Evidence map›Paper›PMID 28846472›Full record

ReviewHuman vaccines & immunotherapeutics2017

The current state of food allergy therapeutics.

Meng Chen, Michael Land

Open access · bronzeAbstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. An Overview of Adherence-What It Is and Why It Is Important.The journal of allergy and clinical immunology. In practice · 2024
    Review
  3. Article
  4. Review
  5. Article
  6. Therapeutic perspectives in food allergy.Journal of translational medicine · 2020
    Review
  7. Article
  8. Hypoallergenic Proteins for the Treatment of Food Allergy.Current allergy and asthma reports · 2019
    Review
  9. Review
  10. Broad perspectives of allergen specific immunotherapy.Human vaccines & immunotherapeutics · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Meng Chena Department of Medicine , Division of Allergy/Immunology, University of California , San Diego , CA , USA.
Michael Landb Kaiser Permanente , San Diego , CA , USA.
Kaiser Permanente San Diego Medical Center · USUniversity of California, San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of IgE mediated food allergy is an increasing public health concern. The current standard of treatment is strict avoidance of the offending food(s). There are no FDA approved treatments for food allergy. This review will provide an overview of strategies currently under investigation for the treatment of food allergy. The main focus of research has been directed at various forms of immunotherapy, including oral, sublingual and epicutaneous delivery routes. While oral immunotherapy (OIT) has shown the greatest promise for efficacy in terms of amount of protein that can be ingested, it has also demonstrated less tolerability and a less favorable safety profile as compared to sublingual immunotherapy (SLIT) and epicutaneous immunotherapy (EPIT), which offers the least protection but has the best safety and tolerability profile. Investigation is also underway for modified antigens that may be used for immunotherapy and for adjuncts that may help facilitate immunotherapy, including biologics such as anti-IgE therapy, and also probiotics. There are also a number of preclinical concepts that are being evaluated to manipulate the antigens and/or the immune system that may one day be translatable to patients.

Indexed as

Desensitization, ImmunologicAdministration, SublingualAllergensAnimalsAnti-Allergic AgentsAntibodies, Anti-IdiotypicFood HypersensitivityHumansImmunoglobulin EMedicine, Chinese TraditionalMiceOmalizumabProbioticsSublingual ImmunotherapyAllergensAnti-Allergic AgentsAntibodies, Anti-Idiotypicanti-IgE antibodiesImmunoglobulin EOmalizumabepicutaneous immunotherapyfood allergymodified food allergensomalizumaboral immunotherapysublingual immunotherapytraditional chinese medicine

Identifiers

PMID28846472
PMCPMC5647972
OpenAlexW2745687561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.